UNSPSC 51422504: Amcinonide

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 423W026MA9. European Medicines Agency schedules Amcinonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05404MIG. Amcinonide generally arises in the molecular formula C28H35FO7.

UNSPSC 51422504 Amcinonide is a Commodity code that state and local governments use to classify pharmaceutical products, specifically corticosteroid medications. The recent opportunities posted under this code, however, show a significant mismatch: Seminole County, Florida's IFB solicitation tags naloxone and drug deactivation systems under the amcinonide code, while the Texas Health and Human Services Commission's RFI addresses direct-to-manufacturer prescription programs with no specific pharmaceutical products named. The code shows little relevant recent activity aligned with its nominal scope as a corticosteroid agent; the naloxone procurement is an opioid-antagonist product outside the amcinonide category, and the Texas HHS RFI is a market-intelligence exercise focused on pharmacy benefit contracting models rather than a product procurement.

Seminole County's IFB60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, solicits 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The Texas RFI HHS0017013, issued April 3, 2026, seeks vendor information on direct pharmaceutical contracting capabilities for a state employee and retiree pharmacy program, with no fixed procurement volume, timeline, or award value. Neither opportunity represents active demand for amcinonide itself. State and local procurement under this code lacks visible recent volume; bid this code only after confirming that a specific jurisdiction's RFP or IFB explicitly names amcinonide or other topical corticosteroid products as line items.